Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-17

Clinical Trial Update: A Study to Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex [Phase 4]

View source ↗

Summary

A Phase 4 study is evaluating how children with Dravet syndrome or Lennox-Gastaut syndrome transition from artisanal cannabidiol to Epidiolex, with recruitment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPIDIOLEX (Cannabidiol)

Snippet

Sponsor: Elizabeth Donner | Conditions: Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS) | Phase 4 | Status: NOT_YET_RECRUITING